skip to main content
Show Results with:

Results 1 - 10 of 62  for Everything in this catalogue

results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

The gut microbiota and immune checkpoint inhibitors

Humphries, Audrey; Daud, Adil

Human vaccines & immunotherapeutics. Volume 14:Issue 9 (2018); pp 2178-2182 -- Landes Bioscience -- Taylor & Francis

Online access

2
Material Type:
Article
Add to My workspace

Revisiting RECIST: the case of treatment beyond progression

Daud, Adil I

The Lancet oncology. Volume 19:Issue 2 (2018); pp 157-159 -- Elsevier Science

Online access

3
Material Type:
Article
Add to My workspace

Nivolumab plus ipilimumab in the treatment of advanced melanoma

Tsai, Katy; Daud, Adil

Journal of hematology & oncology. Volume 8:Issue 1 (2015); pp 1-4 -- BioMed Central

Online access

4
Material Type:
Article
Add to My workspace

Management of Treatment‐Related Adverse Events with Agents Targeting the MAPK Pathway in Patients with Metastatic Melanoma

Daud, Adil; Tsai, Katy

The oncologist. Volume 22:Number 7 (2017, July); pp 823-833 -- AlphaMed Press

Online access

5
Material Type:
Article
Add to My workspace

Management of treatment�related adverse events with agents targeting the mapk pathway in patients with metastatic melanoma

Daud, Adil; Tsai, Katy

The oncologist. VOL 22; NUMBER 7, ; 2017, 823-833 -- ALPHAMED PRESS

Check library holdings

6
Material Type:
Article
Add to My workspace

Negative but not futile: MAGE-A3 immunotherapeutic for melanoma

Daud, Adil I

The Lancet oncology. Volume 19:Number 7 (2018, July); pp 852-853 -- Elsevier Science

Online access

7
Material Type:
Article
Add to My workspace

Revisiting RECIST: the case of treatment beyond progression

Daud, Adil I

The Lancet oncology. Volume 19:Number 2 (2018, February); pp 157-159 -- Elsevier Science

Online access

8
Material Type:
Article
Add to My workspace

Management of Treatment‐Related Adverse Events with Agents Targeting the MAPK Pathway in Patients with Metastatic Melanoma

Daud, Adil; Tsai, Katy

The oncologist. Volume 22:Number 7 (2017, July); pp 823-833 -- AlphaMed Press

Online access

9
Material Type:
Article
Add to My workspace

Negative but not futile: MAGE-A3 immunotherapeutic for melanoma

Daud, Adil I

The Lancet oncology. Volume 19:Issue 7 (2018); pp 852-853 -- Elsevier Science

Online access

10
Material Type:
Article
Add to My workspace

The gut microbiota and immune checkpoint inhibitors

Humphries, Audrey; Daud, Adil

Human vaccines & immunotherapeutics. Volume 14:Number 9 (2018, September 2nd); pp 2178-2182 -- Taylor & Francis

Online access

Results 1 - 10 of 62  for Everything in this catalogue

results 1 2 3 4 5 next page

Refine Search Results

Refine my results

Access Options 

  1. Request to Reading Room  (49)
  2. Online: Reading Room only  (36)
  3. Purchase a copy  (30)
  4. Refine further open sub menu

Material type 

  1. Articles  (61)
  2. Books  (1)
  3. Refine further open sub menu

Creation date 

From To
  1. Before2012  (1)
  2. 2012To2013  (1)
  3. 2014To2014  (4)
  4. 2015To2016  (17)
  5. After 2016  (39)
  6. Refine further open sub menu

Language 

  1. English  (2)
  2. Arabic  (1)
  3. Refine further open sub menu

Additional Features 

  1. Abstract  (40)
  2. No Abstract  (21)
  3. Refine further open sub menu

Try a new search

Ignore my search and look for everything

by this Author/Contributor:

  1. Daud, Adil
  2. Hamid, Omid
  3. Ribas, Antoni
  4. Robert, Caroline
  5. Ebbinghaus, Scot

Searching Remote Databases, Please Wait